Overview
Hemifacial hyperplasia, also known as facial hemihypertrophy or hemifacial hypertrophy, is a rare congenital condition characterized by asymmetric overgrowth of one side of the face. The condition involves enlargement of both soft tissues and bony structures on the affected side, leading to noticeable facial asymmetry. Structures that may be affected include the maxilla, mandible, teeth, tongue (hemimacroglossia), lips, cheeks, ears, and overlying skin and subcutaneous tissues. The degree of asymmetry can range from mild, barely perceptible differences to significant disfigurement that impacts function and appearance. Hemifacial hyperplasia may occur as an isolated finding or as part of broader overgrowth syndromes such as Beckwith-Wiedemann syndrome, Proteus syndrome, or other segmental overgrowth conditions. When isolated, the cause is often unknown, though somatic mosaicism for growth-promoting genetic mutations has been implicated in some cases. Dental abnormalities are common and may include premature eruption, enlarged teeth (macrodontia), and malocclusion on the affected side. In some cases, there may be associated functional issues including difficulties with chewing, speech, and dental alignment. Treatment is primarily supportive and symptomatic, tailored to the severity of the asymmetry and functional impairment. Orthodontic management is frequently required to address dental and occlusal abnormalities. Surgical interventions, including orthognathic surgery, soft tissue reduction, and reconstructive procedures, may be considered to improve facial symmetry and function, typically after skeletal growth is complete. A multidisciplinary approach involving craniofacial surgeons, orthodontists, dentists, and other specialists is recommended for optimal management. Regular monitoring during childhood is important to track the progression of asymmetry during growth periods.
Also known as:
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hemifacial hyperplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hemifacial hyperplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hemifacial hyperplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hemifacial hyperplasia.
Community
No community posts yet. Be the first to share your experience with Hemifacial hyperplasia.
Start the conversation →Latest news about Hemifacial hyperplasia
No recent news articles for Hemifacial hyperplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hemifacial hyperplasia
What is Hemifacial hyperplasia?
Hemifacial hyperplasia, also known as facial hemihypertrophy or hemifacial hypertrophy, is a rare congenital condition characterized by asymmetric overgrowth of one side of the face. The condition involves enlargement of both soft tissues and bony structures on the affected side, leading to noticeable facial asymmetry. Structures that may be affected include the maxilla, mandible, teeth, tongue (hemimacroglossia), lips, cheeks, ears, and overlying skin and subcutaneous tissues. The degree of asymmetry can range from mild, barely perceptible differences to significant disfigurement that impacts
How is Hemifacial hyperplasia inherited?
Hemifacial hyperplasia follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hemifacial hyperplasia typically begin?
Typical onset of Hemifacial hyperplasia is neonatal. Age of onset can vary across affected individuals.